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Abstract
 .Niemann–Pick disease type C NP-C is an autosomal recessive disorder characterized by the sequestration and trapping
of endocytosed cholesterol in lysosomes. The NPC1 gene on chromosome 18 was recently identified but its physiological
function remains unknown. We have studied the lipid compositions of cultured human NP-C fibroblasts and mouse
SPM-3T3 cell line derived from the C57BLrKsJ NP-C model mouse, which belongs to the same complementation group.
Fibroblasts derived from apparently normal age-matched individuals and a subline of SPM-3T3 cells which restores
cholesterol metabolism by transfer of human chromosome 18 were used as controls. Levels of free cholesterol in whole cell
homogenates increased about 1.5-fold in human NP-C fibroblasts and mouse SPM-3T3 cells, while in the plasma
membrane, cholesterol content did not significantly change in NP-C fibroblasts but rather decreased in SPM-3T3 cells. The
total phospholipid content did not significantly change; however, among phospholipid head groups, increases in sphingo-
myelin and decreases in other classes were observed in human NP-C fibroblasts and mouse SPM-3T3 cells. The ratios of
saturated fatty acids to unsaturated fatty acids increased in both human and mouse cells. The increase was also confirmed in
the plasma membrane fraction of SPM-3T3 cells. Membrane fluidity was examined using a 1,6-diphenyl-1,3,5-hexatriene
 .DPH fluorescent probe. The DPH anisotropy values were markedly increased in NP-C fibroblasts and in SPM-3T3 cells.
The results suggest that a NP-C mutation causes complex alterations in cellular lipid contents and biophysical properties of
the membrane. q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
 .Niemann–Pick disease type C NP-C is a genetic
disorder characterized by progressive neurologic de-
terioration, hepatosplenomegaly and foamy bone
marrow cells. Cultured skin fibroblast from patients
with NP-C show a lysosomal accumulation of unes-
terified cholesterol and failure of low-density lipopro-
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 .tein LDL to stimulate cholesterol esterification. The
defect has been considered in a metabolic process
that affects the relocation of cholesterol from lyso-
wsomes to other cellular sites for reviews, see Refs.
w xx1,2 . Two complementation groups have been iden-
w xtified 3,4 . The gene for one major complementation
group has been assigned to human chromosome 18
w x w x4,5 and the gene was recently identified 6 but the
gene for the minor second group has not been as-
signed. Two mutant mouse models BALBrc and
.C57BLrKsJ strains for NP-C have been found and
w xmaintained 7,8 . Both strains are genetically authen-
tic models for the first major complementation group
of NP-C, showing the same biochemical abnormali-
w xties to NP-C 9 , cross-mating between the two strains
w x10 , transferring human chromosome 18 to a cell line
w xderived from the C57BLrKsJ model mouse 11 , by
complementation analysis in cell hybrids between
w xNP-C fibroblasts and the cell line 12 , and by recent
w xidentification of the mutation in NPC1 gene 13 .
Recently, we found that NP-C fibroblasts show an
abnormal metabolism of ganglioside GM2 and the
abnormality is not corrected in a culture condition
w xthat eliminates the accumulation of cholesterol 14 .
The findings suggest that a defect in the NPC1 gene
may involve intracellular transport of both cholesterol
and gangliosides. In addition, we have noticed that
NP-C cells show a resistance to cytotoxic effect of a
polyene antibiotic, filipin, which binds to membrane
w xsterols and presumably damages the membrane 15 .
Since a common abnormality in filipin-resistant
mammalian mutant cells is a reduction of membrane
w xsterols 16 , we have speculated that cholesterol con-
tents in the plasma membrane may be decreased or
that the contents of other lipid classes that constitute
the plasma membrane may be altered in NP-C fibrob-
lasts. In this paper, we have described that NP-C
fibroblasts derived from the first major complementa-
tion group and a cell line from the C57BLrKsJ
model mouse have a decreased content of unsaturated
fatty acid and have decreased membrane fluidity.
2. Materials and methods
2.1. Cells and cell culture
 .Three fibroblasts strains UCH, TAN, and YON
were established from Japanese NP-C children and
 .one strain 93059 was established from a Caucasian
child. In some experiments, two other strains
 .GM0110A, GM3123 purchased from the Human
Genetic Mutant Cell Depository, Coriell Institute for
 .Medical Research Camden, USA and one fibroblast
 .strain KAI derived from a 38-year old Japanese
NP-C patient were included. All these human NP-C
strains were found to belong to the first major com-
w xplementation group of NP-C 14 . As control fibrob-
lasts, four strains derived from apparently normal
 .Japanese children aged 3–4 years old and, in some
experiments, three strains derived from apparently
 .normal Japanese adults aged 42–55 years old were
used. A mouse SPM-3T3 cell line was established
according to the 3T3 transfer schedule from a ho-
mozygous embryo of C57BLrKsJ model mouse of
w xNP-C 9 and a SPMneo18 cell line, a subline of
SPM-3T3 cells which restored cholesterol metabolism
w xby transfer of human chromosome 18 11 , was used
as control. Cells were maintained in Dulbecco’s mod-
 .ified Eagle’s medium DMEM supplemented with
 .10% fetal bovine serum FBS . Because fragments of
human chromosome 18 introduced in SPMneo18 cells
is randomly excluded, the SPMneo18 cells were cul-
tured in the presence of G418 Geneticin, Gibco, NY,
.USA and, at intervals, the cholesterol-non-accu-
mulating phenotype was examined by filipin staining
w x9 . The cell populations containing less than 5%
cholesterol-accumulating cells were used for lipid
analysis.
2.2. Plasma membrane isolation
Unless otherwise specified, confluent-resting cells
in thirty 100-mm dishes were used for each plasma
membrane isolation. When the cells attained conflu-
ence, the medium was replaced. Cells on the fourth
day after replacement were defined as confluent-rest-
ing. In some experiments, the plasma membrane of
proliferating cells was isolated from sparsely prolifer-
ating cells in seventy 100-mm dishes. The plasma
membrane was purified according to the procedures
w xof Bauvois 17 . Briefly, washed cells were sus-
pended in sucrose homogenization medium, followed
by tight-fitting Dounce homogenization. The ho-
mogenate was centrifuged to remove the nuclear
pellet and the supernatant was recentrifuged. Plasma
membrane fraction was separated from the resulting
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pellet using sucrose gradient centrifugation. The
membrane fraction was pelleted at 30,000=g for 30
 .min after dilution with 10 mM TrisrHCl pH 7.4
containing 0.154 M NaCl and 0.2 mM MgCl . The2
final pellet was stored at y808C prior to analyses.
All steps were carried out at 48C. Marker enzymes
were measured to establish purity of the plasma
membrane fraction. The specific activity of 5X-
nucleosidase was measured by the method of Heppel
w x 2qand Hilmore 18 , and Mg -ATPase was measured
w xunder conditions described by Lotersztajn et al. 19
with slight modifications except that phosphate re-
w xlease was determined according to Prpic et al. 20 .
The activity of 5X-nucleosidase and Mg2q-ATPase
were increased by approximately 5- to 7-fold and
about 3- to 5-fold, respectively, in purified plasma
membranes as compared with those in the crude
homogenates. Protein concentrations were determined
by the Bio-Rad Protein Assay Kit I based on the
w xBradford method 21 , using lyophilized bovine g-
globulin as a standard.
2.3. Lipid extraction
Whole cellular lipids were extracted from cells
cultured in three 100-mm dishes confluent-resting
. cultures or ten 100-mm dishes proliferating cul-
.tures or from plasma membrane fractions purified as
above. Lipid extracts were prepared by homogeniza-
tion of cell pellets in 50 vol. of chloroform–methanol
 . w x2:1, vrv 22 . After brief centrifugation, the solvent
extracts were recovered and the deposit was re-ex-
tracted as above. The pooled extracts were partitioned
against 0.2 vol. of H O and the lower phase was2
recovered. The extract was dried under N and dis-2
solved in chloroform.
2.4. Determination of cholesterol and phospholipids
Total cholesterol content of the lipid fraction was
assayed by an enzymatic method using a cholesterol
determination kit Wako Pure Chemical Industries,
.Osaka . For this purpose, the total lipid fraction,
suspended in 20 ml of isopropanol, was incubated for
5 min at 378C in 3 ml of assay mixture containing 4.8
units cholesterol esterase, 0.93 units cholesterol oxi-
dase, 15.6 units peroxidase, 2.85 pmol DAOS, 0.6
pmol 4-aminoantipyrine and 13 units ascorbic oxi-
dase. The absorbance at 600 nm was measured. To
assay free cholesterol, the total lipid fraction was
incubated in the same mixture but without cholesterol
esterase. The level of phosphorus in the lipid extracts
was determined according to the method described by
w xAmes 23 . Phospholipid values were calculated by
multiplying the average value of phosphorus by a
factor of 25 to yield the level of phospholipid in
milligrams.
2.5. Separation and quantification of phospholipids
The phospholipid classes were separated by two-
dimensional thin-layer chromatography on a glass
HPTLC plate Art. 5641, Merk. Darmstadt, Ger-
.many , in a solvent system of chloroform–methanol–
 .15.1 N ammonia water 65:35:5.5 vrv in the first
dimension, and chloroform–acetone–methanol–acetic
 .acid–water 3:4:1:1:0.5 vrv in the second develop-
w xment 24 . The spots were visualized by spraying
with 0.2 M cupric acetate in 8% phosphoric acid and
heating at 2108C for 10 min. The density of spots
visualized by cupric acetate–phosphoric acid regent
was quantitatively determined at 500 nm with a TLC
 . w xdensitometer CS-9000, Shimadzu, Kyoto 25 . The
standards for quantitative determination by TLC-
 .densitometer were phosphatidylethanolamine PE ,
 .  .phosphatidylcholine PC , phosphatidylinositol PI ,
 .  .phosphatidylserine PS and sphingomyelin SM .
2.6. Fatty acid analysis
Fatty acid analysis was done by the method of
w xMacGee and Allen 26 . Fatty acids were extracted
with n-hexane after saponification of total lipids from
the homogenized cells and plasma membrane and
neutralization. Then trimethyl-a ,a ,a-trifluoro-m-
tolyl ammonium hydroxide was added to take up
fatty acids from the hexane phase, followed by meth-
ylation on the capillary column Omegawax 320 0.32
. mm, 30 m, Supelco of a gas chromatography GC-
.14A, Shimadzu . The initial temperature was 1508C
and the temperature was raised 108C per min to a
final temperature of 2708C. The peak area was calcu-
 . w xlated with Chromatopack C-R5A, Shimadzu 27 .
2.7. Membrane fluidity
Membrane fluidity was monitored according to the
w xmethod of Kawato et al. 28 . In brief, a lipophilic
 .probe, 1,6-diphenyl-1,3,5-hexatriene DPH was
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added to the homogenized cells and embedded in the
membrane by incubation at 378C for 20 min. Fluores-
cence intensity was measured with a fluorescence
 .spectrophotometer FP-2070, JASCO . The excitation
wavelength was 362 nm, and the emission light 426
.  .nm was polarized vertically I and horizontallyv
 .I by a polarizing filter. Steady-state emission ani-h
 .sotropy r was calculated as follows.
rs I y I r I q2 I .  .v h v h
2.8. Statistical analysis
Statistical analysis was performed using Student’s
t-test.
3. Results
3.1. Lipid analysis
Cellular concentrations of cholesterol and phos-
pholipids in mouse SPM-3T3 cells are shown in Fig.
1. Because the level of cellular cholesterol contents
may be different between proliferating and resting
states, as demonstrated in our preliminary observation
w x9 , the levels of cellular cholesterol content were
examined at different proliferating states. Free choles-
terol, esterified cholesterol and phospholipid were
 .higher in cells at the proliferating state Fig. 1A than
 .in those at the resting state Fig. 1C in both SPM-3T3
 .and control SPMneo18 cell lines. The most promi-
nent difference was the content of esterified choles-
terol, whose content in the resting cells were approxi-
mately 1r3–1r6 of those in the proliferating cells.
The contents of cholesterol and phospholipids in the
plasma membrane were also higher in the proliferat-
 .  .ing cells Fig. 1B than in the resting cells Fig. 1D .
The contents of free cholesterol in the whole cell
homogenate from SPM-3T3 cells were significantly
higher than those in control cells. The
cholesterolrphospholipid ratios were 2- to 3-fold
higher in SPM-3T3 cells than in controls in whole
cell homogenates either at a proliferating state or
resting state. This finding well agrees with the find-
ings that free cholesterol accumulates in the liver and
w xspleen of the model mice 1,2,7,8 . On the other
hand, levels of cholesterol and cholesterolrphos-
pholipid ratio in the plasma membrane of SPM-3T3
cells were lower than those of control cells both in
proliferating and resting cultures. We have speculated
 .  .Fig. 1. Concentration of lipids in whole cell homogenates A, C and in plasma membrane-enriched fractions B, D from proliferating
 .  . 6  .  .A, B and resting C, D mouse cell lines. Values are mmolr10 cells for free cholesterol FC , cholesteryl ester CE and phospholipids
 .  .PL , and molar ratios for FCrPL. Open columns are values for control SPMneo18 cells and shaded columns are values for SPM-3T3
cells. Error bar is mean and standard deviation of triplicated samples. ) P-0.05, )) P-0.005, ))) P-0.001.
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 .  .Fig. 2. Concentrations of lipids in whole cell homogenates A and in plasma membrane-enriched fragments B of cultured human
fibroblasts from four childhood NP-C patients, one adult NP-C patient, four normal childhood controls, and three normal adult controls.
6  .  .  .Values are mmolr10 cells for free cholesterol FC , cholesteryl ester CE and phospholipids PL and molar ratios for FCrPL. Error
bar is mean and standard deviation of five independent samples. ) P-0,05, )) P-0.01, ))) P-0.005, )))) P-0.001.
that the decreased plasma membrane cholesterol may
be associated with filipin-resistance in NP-C fibrob-
w xlasts 15 . Levels of phospholipids in proliferating
cells were not significantly different between SPM-
3T3 and control cells but those in resting cells were
higher in SPM-3T3 cells than in control cells.
Next, we studied cholesterol and phospholipid con-
tents in whole cell homogenates and enriched plasma
membrane fractions of human NP-C fibroblasts at the
resting state. Since we noticed that contents of
cholesterol in fibroblasts vary by cellular aging in
vitro and in vivo, we used cell strains from age-
matched controls and with similar proliferating poten-
tials. As shown in Fig. 2, contents of total and free
cholesterol in the whole cell homogenates of resting
NP-C fibroblasts were higher than the controls. How-
ever, free cholesterol contents in the plasma mem-
brane fractions were not significantly altered, except
for adult NP-C cells. The contents of phospholipids
in whole cells and in plasma membrane fractions did
not change between controls and NPC fibroblasts,
except for adult NP-C cells.
3.2. Phospholipid classes
Thin-layer chromatogram of mouse SPM-3T3 cells
showed a marked increase in lysophosphatidylcholine
 . LPC spraying with Ninhydrin regent was negative
.but Dittmer regent was positive, data not shown . The
LPC contents of resting SPM-3T3 cells was elevated
about 2.5-fold, as compared to control cells. The
 .sphingomyelin SM in SPM-3T3 cells was elevated
about 1.5 folds when compared with that in control
 .cells. While the contents of phosphatidylcholine PC ,
 .phosphatidylethanolamine PE and phosphatidylinos-
 .itolqphosphatidylserine PIqPS were lower in
 .SPM-3T3 cells than in control cells Table 1 . Even-
tually, the sum of these phospholipid classes were not
significantly altered between SPM-3T3 65.7 mgrmg
. dry weight and control cells 66.1 mgrmg dry
.weight . The increased level of LPC was accounted
for by increased levels of total phospholipids in
 .resting SPM-3T3 cells Fig. 1 .
In human NP-C fibroblasts, the content of SM was
significantly increased, while that of PC, PE and
 .PIqPS was decreased Table 1 . The sum of these
phospholipid classes between NP-C 28.95 mgrmg
. dry weight and control cells 30.46 mgrmg dry
.weight were not significantly changed. Abnormal
increases of LPC were not detected in NP-C fibrob-
lasts. Interestingly, PErPC ratios were significantly
higher in most NP-C fibroblasts examined.
3.3. Fatty acid composition
The ratio of the sum of saturated fatty acids C14–
.C26 to that of unsaturated fatty acids was 0.55"0.04
in mouse SPM-3T3 cells and 0.44"0.01 in control
 .cells Table 2 . The increased ratio in SPM-3T3 cells
is associated with increased C18:0 and decreased
C16:1. The composition of C18:0 in SPM-3T3 was
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Table 1
Contents of individual phospholipid classes in childhood NP-C fibroblasts and mouse cells
 .  .  .Phospholipid class Control children ns4 NP-C ns4 Control SPMneo18 SPM-3T3
a cPC 14.63"2.84 10.87"0.83 27.38"0.02 25.65"0.04
a cPE 6.50"0.60 5.11"0.31 17.77"0.13 16.17"0.53
b cPIqPS 5.59"1.72 4.10"0.60 12.99"0.17 12.37"0.04
a cSM 3.74"0.41 8.87"0.64 7.96"0.02 11.51"0.04
bPErPC 0.37"0.02 0.47"0.06 0.65"0.01 0.64"0.01
The values are expressed as mgrmg dry weight of total phosphorus and expressed as the mean"S.D. of duplicated measurements of two
independent experiments.
Abbreviations: PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingo-
myelin.
abRepresent significant levels of P-0.001 and P-0.05, respectively, from each level of normal controls.
cRepresents significant levels of P-0.005 from each level of control.
1.4-fold in control cells and that of C16:1 was 0.2-fold
in control cells. In the plasma membrane, C16:0 was
elevated, C16:1 decreased, C18:0 remained un-
changed and the ratio of saturatedrunsaturated fatty
acids was increased.
Table 2
 .Fatty acid compositions % of total fatty acids in whole cell and
plasma membrane of the mouse cell lines
Whole cell Plasma membrane
Control SPM-3T3 Control SPM-3T3
C14:0 0.80 0.52 0.31 1.07
C16:0 11.48 11.72 8.88 18.80
C16:1 8.55 1.70 13.00 6.50
C18:0 13.23 18.47 13.48 13.25
C18:1 28.22 29.43 24.29 28.04
C18:2 1.52 1.40 0.36 1.32
C20:0 1.11 0.86 0.97 1.28
C20:4 6.76 7.93 8.94 6.57
C22:0 0.62 ND 0.79 0.42
C22:6 3.36 2.98 3.27 2.73
C24:0 3.22 3.91 3.01 2.52
C26:0 ND ND 0.16 0.11
Others 21.54 21.01 20.37 17.65
aSum of unsaturated FFA 69.55 64.52 72.39 62.50
aSum of saturated FFA 30.46 35.48 27.61 37.50
aSaturatedrunsaturated 0.44 0.55 0.38 0.6
Fatty acid composition in the total lipid extracts was examined by
GLC as described in Section 2. Values are % of total fatty acids
and are expressed as the mean of duplicated readings of two
independent experiments in whole cells and of one experiment in
the plasma membrane fraction. S.D. values of the means of
whole cells were 1–15%.
aRepresents significant differences of P -0.005 from the level
of control.
In human NP-C fibroblasts, increased ratios of
 .saturatedrunsaturated fatty acids C14–C26 with an
increase of C18:0 and with reductions of C16:1 and
 .C18:1 was observed Table 3 . Decreases in the
content of unsaturated fatty acids with a marked
reduction in C16:1 were common findings both in
Table 3
 .Fatty acid compositions % of total fatty acids in whole cell
homogenates of childhood NP-C fibroblasts
 .  .Control ns4 NP-C ns4
C14:0 1.26"0.12 0.72"0.19
C16:0 18.47"0.75 16.75"7.67
C16:1 5.15"1.56 1.97"0.41
C18:0 14.79"0.90 20.91"4.00
C18:1 28.70"2.31 22.75"3.04
C18:2 4.68"3.32 10.32"1.13
C18:3 0.20"0.15 0.34"0.10
C20:0 0.18"0.16 0.34"0.04
C20:4 9.00"0.98 11.45"1.04
C22:0 0.36"0.96 0.36"0.12
C22:6 2.35"2.40 0.88"0.27
C24:0 2.38"0.12 1.71"0.41
C26:0 0.09"0.06 0.33"0.39
Others 13.05"2.11 11.66"1.40
aSum of unsaturated FFA 64.00"0.96 58.96"4.02
aSum of saturated FFA 36.00"0.96 41.04"4.02
aSaturatedrunsaturated 0.56"0.08 0.70"0.13
Values are % of total fatty acids and are expressed as the mean of
duplicated measurements of two independent experiments in
whole cell homogenates.
aRepresents significant differences of P -0.005 from the level
of normal children.
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human NP-C fibroblasts and the cell line derived
from the model mouse.
3.4. Membrane fluidity
The anisotropy values were measured with DPH as
a fluorescent probe in the whole cells and plasma
membrane of cell lines derived from the NP-C model
mouse. The anisotropy value for control mouse cells
was 0.199"0.004 in the whole cells, while that for
SPM-3T3 cells was 0.233"0.003, which was about
 .15% higher than controls P-0.0001 . In the plasma
membrane, the anisotropy value for SPM-3T3 cells
was 0.254"0.002, which was also 30% higher than
 .that for control cells 0.204"0.003, P-0.0001 .
The increased anisotropy values in the whole cells
and enriched plasma membrane fraction indicated a
decreased membrane fluidity in SPM-3T3 cells. The
DPH fluorescent anisotropy values in human NP-C
fibroblasts were also significantly higher than those
 .in the controls Table 4 . The findings suggest that
the membrane fluidity is reduced in NP-C fibroblasts
and in the cell line derived from the model mouse. In
the strain derived from an adult type NP-C patient,
the anisotropy value was not significantly altered.
The cells from this patient showed intracellular accu-
mulation of free cholesterol and a mild defect in low
density-lipoprotein induced cholesteryl ester forma-
w xtion 9,14 , but did not show GM2 ganglioside accu-
w xmulation 14 . It is considered that the defect in this
patient was mild and, therefore, did not affect the
membrane fluidity.
Table 4
Fluorescent anisotropy values in whole cell of NP-C fibroblasts
treated with DPH
 .Control children ns4 0.180"0.002
a .NP-C children ns6 0.198"0.009
 .Control adults ns3 0.184"0.005
 .NP-C adult ns1 0.180"0.001
Two milliliters of cell suspension in PBS 0.075 mg proteinrml
.in whole cell and 0.02 mg proteinrml in plasma membrane was
 .added to 2 ml of DPH solution 190 mM in a cuvette and the
fluorescent anisotropy was measured after incubation at 378C for
20 min. The values denote mean"S.D. of four independent
determinations. aRepresents a significant difference of P -
0.0001 from the control level.
4. Discussion
Common abnormalities in human NP-C fibroblasts
and mouse SPM-3T3 cells revealed in this study were
increased levels of cholesterol and sphingomyelin,
decreased levels of PC, PE and PIqPS, increased
 .levels of saturated fatty acids C14–C26 and satu-
ratedrunsaturated fatty acid ratios, and an increased
DPH anisotropy in the whole cell homogenate.
Among these findings, a decrease in unsaturated fatty
acid with reduction of C16:1 and an increased level
of DPH anisotropy were also demonstrated in the
plasma membrane fraction of SPM-3T3 cells.
In the liver and spleen from patients with NP-C, it
has been shown that the concentrations of total
cholesterol, sphingomyelin and total phospholipids,
w xincrease several folds 29 . In the liver and spleen of
C57BLrKsJ model mice, cholesterol and sphingo-
w xmyelin are known to be increased 3- to 5-fold 30
w xand 3- to 10-fold 30,31 , respectively, with a mild
increase in total phospholipids. Our observations in
SPM-3T3 cells showed 2- to 3-fold increases in free
cholesterol and 1.5 folds increase in sphingomyelin.
In human NP-C fibroblasts, the content of sphingo-
myelin and free cholesterol increased about 2 folds
and 1.5 folds, respectively. Total phospholipids in
resting human NP-C cells remained unchanged in
terms of decreases in PC, PE and PIqPS, and total
phospholipids in resting mouse SPM-3T3 cells in-
creased probably by an increase in LPC. Increased
LPC in SPM-3T3 cells is an interesting phenomenon
but the reason for it remains uncertain. The abnormal-
ities in cholesterol, sphingomyelin and total phospho-
lipid content in cultured cells are in good accordance
with those observed in the tissues of affected patients
and affected mice.
We have initiated this study to characterize the
resistance to cytotoxic effects of polyene antibiotics
w xin NP-C fibroblasts 15 , expecting a similar lipid
change observed in the plasma membrane of filipin-
w xresistant LM cell mutants 16 . Except for a decrease
in membrane cholesterol of SPM-3T3 cells, the lipid
changes including the content of SM and unsaturated
fatty acids, and the PErPC ratio in NP-C and SPM-
3T3 cells were opposite from those observed in the
plasma membrane of filipin-resistant LM cell mu-
tants. Although it seems likely that filipin-resistance
is associated with changes in the plasma membrane
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sterol level, our method has failed to show evidence
of decreased plasma membrane cholesterol in human
NP-C fibroblasts.
The NP-C gene product is required for exogenous
 .LDL-derived cholesterol egress from lysosomes and
the inability of cholesterol to leave lysosomes leads
to impaired regulation of cholesterol homeostasis.
The NP-C mutation has no effect on the transport of
endogenously synthesized cholesterol from the endo-
w xplasmic reticulum to the plasma membrane 32 but it
has been shown that there is impaired esterification
of plasma membrane cholesterol following treatment
with sphingomyelinase, indicating that the transport
of cholesterol from the plasma membrane to the
w xendoplasmic reticulum is deficient 33 . More re-
w xcently Garver et al. 34 have shown abnormal ex-
pressions of caveolin-1 protein or mRNA in het-
erozygous and homozygous NP-C fibroblasts, sug-
gesting that a subcellular structure containing cave-
olin-1 is involved in the pathophysiology of NP-C. In
addition to cholesterol and sphingomyelin, it has been
reported that several lipids are changed in tissues of
NP-C patients or the model mice: bis mono-
.acylglycerol phosphate, glucosylceramide, lactosylce-
w x w xramide 1,7,35 , gangliosides GM2 and GM3 29,35 ,
w x w xsphingoid bases 36 and dolichol 37 . Peroxisomal
impairment in NP-C model mice has also been re-
w xported 38 . Although the mechanism of complex
lipid changes in NP-C tissues or cultured cells is
unknown, it seems to be unlikely that lipid composi-
tions and structure of the plasma membrane lipid
bilayer are intact in NP-C cells.
Decreased membrane fluidity in NP-C cells is the
most important finding in this study. Membrane fluid-
ity is a biophysical property of the membrane quanti-
tatively expressing the mobility and the rate of rota-
tional motion of membrane lipid molecules. Changes
in membrane fluidity are known to be linked with the
alteration in physiological process of the cell mem-
branes such as carrier-mediated transport, activities of
w xmembrane bound enzymes and receptor binding 39 .
Cholesterol has a stabilizing effect on the mem-
branes, decreasing fluidity and permeability. In hu-
man NP-C and mouse SPM-3T3 cells cholesterol
levels in whole cells were increased but the levels in
the plasma membrane were not changed but, rather,
decreased. It is difficult to attribute the decrease in
membrane fluidity to the level of plasma membrane
cholesterol. At present decreases in unsaturated fatty
acids ratios in NP-C cells and in plasma membrane of
SPM-3T3 cells and increases in the PErPC ratios
observed in most NP-C cells seem to be associated
with the alteration in membrane fluidity, because
both changes have been suggested to decrease the
w xmembrane fluidity 40 . Dolichol, levels of which are
w xknown to be changed in the NP-C model mouse 41 ,
may be one of factors affecting membrane fluidity in
NP-C.
In conclusion, it was suggested that complex lipid
changes observed in NP-C tissues and cultured cells
may alter the plasma membrane lipid compositions
and structure. Decreased membrane fluidity in cul-
tured cells from NP-C patients and from a murine
model might be the result of alterations in plasma
membrane lipid compositions, changing the cellular
functions to a disadvantage. It will be a future task to
establish whether the function defective in NP-C
directly participates in the homeostasis of membrane
lipid compositions or not.
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